Solugen · 5 hours ago
Process Technician Internship
Character Biosciences is a precision medicine company pioneering targeted therapies for polygenic diseases. They are seeking a talented Research Associate/Senior Research Associate to develop in vitro disease models and perform cell-based assays to support drug discovery efforts.
BiotechnologyChemicalGreenTechManufacturing
Responsibilities
Engineer, maintain, and differentiate iPSC-derived and/or primary human neurons and glia for disease modeling
Develop and perform cell-based functional assays and in vitro assays, including but not limited to high-content cell imaging, ELISA, qPCR, immunoblotting, immunohistochemistry and flow cytometry
Independently plan, execute and troubleshoot experiments and collaborate effectively with team members to solve problems
Coordinate tasks across multiple projects and keep meticulous records
Organize, analyze and communicate results in team meetings
Qualification
Required
BS with 3+ years (or MS with 1+ years) of research experience in neurobiology, stem cell biology or related discipline
Must be nimble and able to work with changing priorities
Must have hands-on experience with mammalian cell culture, assay development, ELISA, and fluorescent microscopy
Ability to work independently and collaboratively
Must have excellent troubleshooting, organizational and communication skills
Preferred
Experience with iPSC-derived neurons and glia is highly desirable
Benefits
Strong equity incentives
Medical
Dental
Vision
401(k)
Accrued paid time off policy
Company
Solugen
Solugen is a carbon negative moleucle factory that replaces petroleum-based products with plant-derived substitutes.
H1B Sponsorship
Solugen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
2021 (2)
2020 (1)
Funding
Current Stage
Late StageTotal Funding
$855.77MKey Investors
US Department of EnergyFounders FundRefactor
2024-06-13Debt Financing· $213.6M
2022-10-28Series D· $200M
2021-09-09Series C· $357M
Recent News
2025-06-19
Google Patent
2025-05-04
Company data provided by crunchbase